Stay updated with breaking news from Array Biopharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Poseida Therapeutics Appoints Charles M. Baum, M.D., Ph.D., to Board of Directors - read this article along with other careers information, tips and advice on BioSpace
Survival rates have increased for many cancers over the past two decades, but there remains an unmet need for more effective therapies. This article...
Survival rates have increased for many cancers over the past two decades, but there remains an unmet need for more effective therapies. This article...
A BRAF-MEK inhibitors are a chemical or drug that restricts the mitogen-activated protein kinase and kinase, enzymes MEK1 and/or MEK2. The chemicals are used to affect the BRAF-MEK pathway which is often overactive in some cancers. Hence, the BRAF-MEK inhibitors have potential for treatment of some cancers, especial...
The current understanding of Chronic Spontaneous Urticaria has greatly improved in recent decades, leading to rising awareness, improved management, better...